Clinical trial
Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers
NCT00020878 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00020878 |
|---|---|
| Title | Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers |
| Official title | Celecoxib for Chemoprevention of Primary Lung Cancer |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | celecoxib |
| Enrollment | 21 |
| Start date | Mar 1, 2001 |
| Primary completion | Nov 1, 2002 |
| Completion | May 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 3, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: